Clinical Trials Browser

Completed × Stomach Neoplasms × Sorafenib × Clear all

Stomach Neoplasms

NCT01187212 2020-01-07

Sorafenib Trial in Advanced and/or Recurrent Gastric Adenocarcinoma: Treatment Evaluation: STARGATE

Phase 2 Completed

195 enrolled

Gastrointestinal

Stomach Neoplasms

NCT01183663 2016-06-03

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

Phase 1 Completed

180 enrolled

BreastCNSDermatologicGastrointestinalGenitourinaryOther hematologic neoplasmPlasma cell

Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Glioblastoma, Melanoma, Multiple Myeloma, Neoplasm Metastasis, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms

NCT01158287 2014-12-31

Sorafenib. ICORG 06-41, V4

Phase 2 Completed

54 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

NCT00663741 2013-06-11

Sorafenib Gastric Cancer Asian Phase I Study

Phase 1 Completed

13 enrolled

Gastrointestinal

Stomach Neoplasms

Clinical Trials

Capecitabine and Cisplatin (XP)+Sorafenib in Advanced Gastric Cancer (AGC): Sorafenib+XP

Sorafenib Trial in Advanced and/or Recurrent Gastric Adenocarcinoma: Treatment Evaluation: STARGATE

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

Sorafenib. ICORG 06-41, V4

Sorafenib Gastric Cancer Asian Phase I Study